507 related articles for article (PubMed ID: 30355631)
1. Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau
Ondrejcak T; Klyubin I; Corbett GT; Fraser G; Hong W; Mably AJ; Gardener M; Hammersley J; Perkinton MS; Billinton A; Walsh DM; Rowan MJ
J Neurosci; 2018 Dec; 38(50):10595-10606. PubMed ID: 30355631
[TBL] [Abstract][Full Text] [Related]
2. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation
Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ
J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein.
Barry AE; Klyubin I; Mc Donald JM; Mably AJ; Farrell MA; Scott M; Walsh DM; Rowan MJ
J Neurosci; 2011 May; 31(20):7259-63. PubMed ID: 21593310
[TBL] [Abstract][Full Text] [Related]
4. Soluble tau aggregates inhibit synaptic long-term depression and amyloid β-facilitated LTD in vivo.
Ondrejcak T; Hu NW; Qi Y; Klyubin I; Corbett GT; Fraser G; Perkinton MS; Walsh DM; Billinton A; Rowan MJ
Neurobiol Dis; 2019 Jul; 127():582-590. PubMed ID: 30910746
[TBL] [Abstract][Full Text] [Related]
5. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
[TBL] [Abstract][Full Text] [Related]
6. Cellular prion protein as a therapeutic target in Alzheimer's disease.
Laurén J
J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
[TBL] [Abstract][Full Text] [Related]
7. PrPC controls via protein kinase A the direction of synaptic plasticity in the immature hippocampus.
Caiati MD; Safiulina VF; Fattorini G; Sivakumaran S; Legname G; Cherubini E
J Neurosci; 2013 Feb; 33(7):2973-83. PubMed ID: 23407955
[TBL] [Abstract][Full Text] [Related]
8. Rapidly reversible persistent long-term potentiation inhibition by patient-derived brain tau and amyloid ß proteins.
Ondrejcak T; Klyubin I; Hu NW; Yang Y; Zhang Q; Rodriguez BJ; Rowan MJ
Philos Trans R Soc Lond B Biol Sci; 2024 Jul; 379(1906):20230234. PubMed ID: 38853565
[TBL] [Abstract][Full Text] [Related]
9. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic Plasticity.
Hu NW; Corbett GT; Moore S; Klyubin I; O'Malley TT; Walsh DM; Livesey FJ; Rowan MJ
Cell Rep; 2018 May; 23(7):1932-1938. PubMed ID: 29768194
[TBL] [Abstract][Full Text] [Related]
11. AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy.
Borreca A; Latina V; Corsetti V; Middei S; Piccinin S; Della Valle F; Bussani R; Ammassari-Teule M; Nisticò R; Calissano P; Amadoro G
Mol Neurobiol; 2018 Oct; 55(10):8124-8153. PubMed ID: 29508283
[TBL] [Abstract][Full Text] [Related]
12. Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.
Koss DJ; Robinson L; Mietelska-Porowska A; Gasiorowska A; Sepčić K; Turk T; Jaspars M; Niewiadomska G; Scott RH; Platt B; Riedel G
Cell Mol Life Sci; 2015 Dec; 72(23):4613-32. PubMed ID: 26070304
[TBL] [Abstract][Full Text] [Related]
13. Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies.
Zhang D; Qi Y; Klyubin I; Ondrejcak T; Sarell CJ; Cuello AC; Collinge J; Rowan MJ
Neuropharmacology; 2017 Jul; 121():231-246. PubMed ID: 28390893
[TBL] [Abstract][Full Text] [Related]
14. APPsα Rescues Tau-Induced Synaptic Pathology.
Bold CS; Baltissen D; Ludewig S; Back MK; Just J; Kilian L; Erdinger S; Banicevic M; Rehra L; Almouhanna F; Nigri M; Wolfer DP; Spilger R; Rohr K; Kann O; Buchholz CJ; von Engelhardt J; Korte M; Müller UC
J Neurosci; 2022 Jul; 42(29):5782-5802. PubMed ID: 35667850
[TBL] [Abstract][Full Text] [Related]
15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
16. Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.
Hu NW; Smith IM; Walsh DM; Rowan MJ
Brain; 2008 Sep; 131(Pt 9):2414-24. PubMed ID: 18678563
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein.
Nieznanska H; Boyko S; Dec R; Redowicz MJ; Dzwolak W; Nieznanski K
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166209. PubMed ID: 34246750
[TBL] [Abstract][Full Text] [Related]
18. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
Chong SA; Benilova I; Shaban H; De Strooper B; Devijver H; Moechars D; Eberle W; Bartic C; Van Leuven F; Callewaert G
Neurobiol Dis; 2011 Dec; 44(3):284-91. PubMed ID: 21807097
[TBL] [Abstract][Full Text] [Related]
19. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
20. Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice.
Rangel A; Madroñal N; Gruart A; Gavín R; Llorens F; Sumoy L; Torres JM; Delgado-García JM; Del Río JA
PLoS One; 2009 Oct; 4(10):e7592. PubMed ID: 19855845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
